Venmax Drugs And Pharmaceuticals Ltd - Stock Valuation and Financial Performance

BSE: 531015 | NSE: | Pharmaceuticals & Drugs | Small Cap

Venmax Drugs&Pharma Share Price

13.49 1.22 9.94%
as on 20-Dec'24 16:59

DeciZen - make an informed investing decision on Venmax Drugs&Pharma

M-Cap below 100cr DeciZen not available

Venmax Drugs And Pharmaceuticals stock performance -

mw4me loader
P/E Ratio (SA):
0.00
Market Cap:
7.1 Cr.
52-wk low:
6.3
52-wk high:
13.5

Is Venmax Drugs And Pharmaceuticals Ltd an attractive stock to invest in?

1. Is Venmax Drugs And Pharmaceuticals Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Venmax Drugs And Pharmaceuticals Ltd is a below average quality company.

2. Is Venmax Drugs And Pharmaceuticals Ltd undervalued or overvalued?

The key valuation ratios of Venmax Drugs And Pharmaceuticals Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

3. Is Venmax Drugs And Pharmaceuticals Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Venmax Drugs And Pharmaceuticals Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Venmax Drugs&Pharma:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Venmax Drugs And Pharmaceuticals Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
ROCE % -6.3%-7.3%-140.9%0%0%0%0%0%0%0%-
Value Creation
Index
-1.5-1.5NANANANANANANANA-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 2.41.90.300.20.50.20000
Sales YoY Gr.--20.6%-86.5%-100%NA213.3%-63.8%-100%NANA-
Adj EPS -0.2-0.3-1.4-0.5-0.5-0.5-0.33.50.40.1-0.4
YoY Gr.-NANANANANANANA-87.8%-72.1%-
BVPS (₹) 0.60.4-3.6-4-4.5-5-5.3-1.8-1.4-1.2-1.8
Adj Net
Profit
-0.1-0.1-0.7-0.2-0.2-0.3-0.21.90.20.10
Cash Flow from Ops. -0.1-0.2-1.1-0.3-0.1-0.30.31.900-
Debt/CF from Ops. -14.9-9.2-1.8-8-47.1-98.80.2-113.6160.1-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales -100%-100%-100%NA
Adj EPS NANANA-72.1%
BVPS-207.6%NANANA
Share Price 12.4% 26.4% 47.8% 222.7%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
Return on
Equity %
-21.2-51.589.112.210.6116-99.1-27.3-9.527.6
Op. Profit
Mgn %
-4.7-7.1-237.60-157.8-53.9-198.2000-117.6
Net Profit
Mgn %
-3.3-7.1-287.30-156.8-57.9-96.8000-78.6
Debt to
Equity
4.58.7-1-1-1-1-0.8-0.4-0.5-0.5-
Working Cap
Days
2924301,303033921953900078
Cash Conv.
Cycle
013930-85-55-729000-283

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 27.60%

Sales growth has been subdued in last 3 years -100.00%

Sales growth is not so good in last 4 quarters at 0.00%

Latest Financials - Venmax Drugs And Pharmaceuticals Ltd.

Standalone Consolidated
TTM EPS (₹) -0.4 -
TTM Sales (₹ Cr.) 0.3 -
BVPS (₹.) -1.8 -
Reserves (₹ Cr.) -6 -
P/BV -7.48 -
PE 0.00 -
From the Market
52 Week Low / High (₹) 6.27 / 13.49
All Time Low / High (₹) 1.10 / 18.20
Market Cap (₹ Cr.) 7.1
Equity (₹ Cr.) 5.2
Face Value (₹) 10
Industry PE 44.3

Management X-Ray of Venmax Drugs&Pharma:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Venmax Drugs&Pharma

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Sales2.431.930.2600.150.470.17000
Operating Expenses 2.542.070.870.230.390.730.500.130.190.10
Manufacturing Costs00000.010.01000.010
Material Costs2.381.910.2400.090.320.29000
Employee Cost 0.040.040.060.050.100.220.060.010.030.02
Other Costs 0.120.120.570.180.190.180.140.120.150.08
Operating Profit -0.11-0.14-0.62-0.23-0.24-0.25-0.33-0.13-0.19-0.10
Operating Profit Margin (%) -4.7%-7.1%-237.0%--157.0%-53.9%-198.0%---
Other Income 000.120000.181.980.420.20
Interest 0000.01000000
Depreciation 00000.010.010.010.010.010.01
Exceptional Items 00-0.840000000
Profit Before Tax -0.12-0.14-1.34-0.24-0.24-0.27-0.161.850.230.09
Tax -0.0400000.010000.02
Profit After Tax -0.08-0.14-1.34-0.24-0.24-0.27-0.161.850.230.06
PAT Margin (%) -3.3%-7.1%-515.0%--156.0%-57.9%-96.8%---
Adjusted EPS (₹)-0.2-0.3-2.6-0.5-0.5-0.5-0.33.50.40.1
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24

Equity and Liabilities

Shareholders Fund 0.340.20-1.87-2.11-2.35-2.62-2.79-0.94-0.71-0.65
Share Capital 5.245.245.245.245.245.245.245.245.245.24
Reserves -4.90-5.04-7.11-7.35-7.59-7.86-8.03-6.18-5.95-5.89
Minority Interest0000000000
Debt1.501.721.852.042.242.522.330.350.350.35
Long Term Debt1.501.7200000000
Short Term Debt001.852.042.242.522.330.350.350.35
Trade Payables1.640.570.080.060.310.400.460.470.330.10
Others Liabilities -0.64-0.740.080.090.130.160.300.330.250.28
Total Liabilities 2.841.750.140.070.330.460.310.210.210.08

Fixed Assets

Gross Block00000.120.120.120.090.070.07
Accumulated Depreciation00000.010.020.030.0100.01
Net Fixed Assets00000.110.100.090.080.070.07
CWIP 0000000000
Investments 0.010.0100000000
Inventories1.470000.110.220000
Trade Receivables0.140.680000.040.040.040.040
Cash Equivalents 00.0300000.08000
Others Assets1.221.030.140.070.110.100.110.100.100.01
Total Assets 2.841.750.140.070.330.460.310.210.210.08

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Cash Flow From Operating Activity -0.10-0.19-1.06-0.26-0.05-0.280.261.9100
PBT -0.12-0.14-1.34-0.24-0.24-0.27-0.161.850.230.09
Adjustment 00-0.09000.010.010.010.010.01
Changes in Working Capital -0.02-0.050.37-0.010.19-0.030.420.05-0.24-0.07
Tax Paid 0.0400000000-0.02
Cash Flow From Investing Activity 000.010-0.1100000
Capex 000.010-0.1200000
Net Investments 0000000000
Others 0000000000
Cash Flow From Financing Activity 0.100.221.020.260.160.28-0.19-1.9800
Net Proceeds from Shares 0000000000
Net Proceeds from Borrowing 000.130.190.160.280000
Interest Paid 0000000000
Dividend Paid 0000000000
Others 0.100.220.890.0700-0.19-1.9800
Net Cash Flow 00.03-0.030000.07-0.0700
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Ratios
ROE (%)-21.22-51.49N/AN/AN/AN/AN/AN/AN/AN/A
ROCE (%)-6.29-7.34N/AN/AN/AN/AN/AN/AN/AN/A
Asset Turnover Ratio1.250.840.2700.751.20.44000
PAT to CFO Conversion(x)N/AN/AN/AN/AN/AN/AN/A1.0300
Working Capital Days
Receivable Days25780051681000
Inventory Days2100002541240000
Payable Days1342114850734410537000

Venmax Drugs And Pharmaceuticals Ltd Stock News

Venmax Drugs And Pharmaceuticals Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Venmax Drugs&Pharma on 20-Dec-2024 16:59 is ₹13.49.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 20-Dec-2024 16:59 the market cap of Venmax Drugs&Pharma stood at ₹7.07.
The latest P/E ratio of Venmax Drugs&Pharma as of 20-Dec-2024 16:59 is 0.00.
The latest P/B ratio of Venmax Drugs&Pharma as of 20-Dec-2024 16:59 is -7.48.
The 52-week high of Venmax Drugs&Pharma is ₹13.49 and the 52-week low is ₹6.27.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Venmax Drugs&Pharma is ₹0.28 ( Cr.) .

About Venmax Drugs And Pharmaceuticals Ltd

No data to display
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.